Intravesically administered BCG combined with IFN‐α vs intravesically administered BCG alone
Disease‐specific mortality ‐ not reported · patients with non‐muscle invasive bladder cancer
It is very uncertain whether intravesically administered BCG combined with IFN‐α changes disease‐specific mortality compared with intravesically administered BCG alone (very low certainty).
1 finding from 1 review
- Intravesical Bacillus Calmette‐Guérin with interferon‐alpha versus intravesical Bacillus Calmette‐Guérin for treating… 2017 · Cochrane Headline outcomes onlyRR 0.38 [0.05, 3.05]1 study · 99 participantsVery low